Literature DB >> 7048848

Fibronectin in experimental granulation tissue.

B Hølund, I Clemmensen, P Junker, H Lyon.   

Abstract

The temporal appearance of fibronectin in experimental granulation tissue has been studied using the immunoperoxidase technique on material fixed in formaldehyde, embedded in paraffin and pretreated with pepsin. Furthermore, the relationship between the distribution of fibronectin and connective tissue fibres, demonstrated as either argyrophilic or red by the van Gieson method, has been investigated. Fibronectin was demonstrated as part of the fibrinous network in the sponge before the formation of granulation tissue. In the development of granulation tissue fibronectin was seen in the initial cellular stage codistributed with the newly formed fibres, first the argyrophilic fibres and later with those stained red by the van Gieson method, too. With maturation of the granulation tissue, predominated by these fibres, the amount of fibronectin was gradually reduced. The presence of fibronectin in the sponge already before the formation of granulation tissue suggests that fibronectin in the initial stage of inflammation derives from plasma. The increase in amount of fibronectin corresponding to the cellular (fibroblastic) proliferation and the formation of fibres, both argyrophilic and van Gieson positive, indicates that fibronectin in young granulation tissue is synthesized by fibroblastic cells. The relationship between the morphologically demonstrated argyrophilic fibres and van Gieson positive fibres and the biochemical type III and type I collagens is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048848     DOI: 10.1111/j.1699-0463.1982.tb00077_90a.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  17 in total

1.  Localization and synthesis of type III collagen and fibronectin in human reparative dentine. Immunoperoxidase and immunogold staining.

Authors:  H Magloire; A Joffre; D J Hartmann
Journal:  Histochemistry       Date:  1988

2.  Demonstration of fibronectin in normal and acutely inflamed appendix.

Authors:  B Hølund
Journal:  Histochemistry       Date:  1987

3.  Deposition of extracellular matrix on intraocular lenses in rabbits: an immunohistochemical and transmission electron microscopic study.

Authors:  S Saika; S Tanaka; S Ohmi; A Minamide; Y Ohnishi; A Yamanaka; A Ooshima; M Kimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

4.  The value of hyaluronidase treatment of different tissues before demonstration of fibronectin by the indirect immunoperoxidase technique.

Authors:  B Hølund; I Clemmensen
Journal:  Histochemistry       Date:  1982

5.  Repair in arterial tissue. Demonstration of fibronectin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique.

Authors:  J Chemnitz; B Collatz Christensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  Sequential appearance of fibronectin and collagen fibres in experimental arthritis in rabbits.

Authors:  B Hølund; I Clemmensen; M Wanning
Journal:  Histochemistry       Date:  1984

7.  Demonstration of fibronectin in normal and injured aorta by an indirect immunoperoxidase technique.

Authors:  B A Jensen; B Hølund; I Clemmensen
Journal:  Histochemistry       Date:  1983

8.  Deposition of extracellular matrix on silicone intraocular lens implants in rabbits.

Authors:  S Saika; S Ohmi; A Ooshima; M Kimura; S Tanaka; Y Okada; Y Ohnishi; A Yamanaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

9.  Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse.

Authors:  S P Andrade; L B Vieira; Y S Bakhle; P J Piper
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

10.  The influence of anti-fibronectin antibodies on interactions involving extracellular matrix components and cells: a possible pathogenic mechanism.

Authors:  M S Atta; R J Powell; I Todd
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.